The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype.
CONCLUSION: Our study demonstrates a beneficial impact for PMRT on overall survival among Luminal A subtype breast cancer patients with T1-2N1 disease. The selection of PMRT should be stratified by molecular subtype and other risk factors.
PMID: 32200207 [PubMed - as supplied by publisher]
Source: Breast - Category: Cancer & Oncology Authors: Wei J, Jiang Y, Shao Z Tags: Breast Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Epidemiology | HER2 | Mastectomy | Science | Study